The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Please provide your email address to receive an email when new articles are posted on . Earlier initiation of donanemab reduced the risk of disease progression on the Clinical Dementia Rating-Global ...

TORONTO - Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease. Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in ...

ADAS-Cog13 difference −12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144 77.4 ...

Please provide your email address to receive an email when new articles are posted on . Active intervention correlated to better cerebral blood flow in areas of memory, executive function and language ...

CHARLESTON — The Alzheimer’s Association has launched a new, free app to help those in the early stages of the disease and their loved ones navigate a dementia diagnosis. According to a release ...

Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...